Announcement • Apr 22
Bio Planet S.A., Annual General Meeting, May 15, 2026 Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time. Announcement • Apr 21
Bio Planet S.A. announces Annual dividend, payable on September 18, 2026 Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026. Announcement • Aug 22
Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025 Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025 Announcement • Jun 01
Bio Planet S.A. announces Annual dividend, payable on July 28, 2025 Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025. New Risk • Nov 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m). New Risk • Oct 06
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m). Reported Earnings • Oct 01
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Reported Earnings • May 29
First quarter 2024 earnings released First quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 26
Full year 2023 earnings released Full year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Dec 07
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year. Reported Earnings • Nov 27
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022). New Risk • Sep 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m). Reported Earnings • Sep 23
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022). New Risk • Jun 15
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change). New Risk • Jun 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change). Announcement • May 27
Bio Planet S.A., Annual General Meeting, Jun 21, 2023 Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time. Valuation Update With 7 Day Price Move • May 15
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year. Reported Earnings • Apr 21
Full year 2022 earnings released Full year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021). Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year. Reported Earnings • Nov 27
Third quarter 2022 earnings released Third quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021). Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improved over the past week After last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year. Announcement • Sep 28
Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG). Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022. Reported Earnings • Sep 25
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021). Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improved over the past week After last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year. Upcoming Dividend • Jul 29
Upcoming dividend of zł0.36 per share Eligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%). Valuation Update With 7 Day Price Move • Jun 04
Investor sentiment improved over the past week After last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year. Announcement • May 20
Bio Planet S.A., Annual General Meeting, Jun 14, 2022 Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time. Valuation Update With 7 Day Price Move • May 03
Investor sentiment deteriorated over the past week After last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Reported Earnings • Nov 10
Third quarter 2021 earnings released The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue. Reported Earnings • Nov 10
Third quarter 2021 earnings released The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment deteriorated over the past week After last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.